Compounds > epiroprim
Page last updated: 2024-08-25

epiroprim and Atypical Mycobacterial Infection, Disseminated

epiroprim has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhople, AM1

Other Studies

1 other study(ies) available for epiroprim and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:1

    Topics: Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Tetrahydrofolate Dehydrogenase; Trimethoprim

2001